Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial - Authors' reply. Rugo HS, Bardia A, Tolaney S. Lancet 2024;404:339-340.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rugo HS, Bardia A, Tolaney S. Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial - Authors' reply. Lancet 2024;404:339-340.
PMID: 39067902